A Study of SC-0191 in Subjects With Metastatic Colorectal Cancer

NCT06363552 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Colorectal Cancer

Interventions

DRUG: SC0191
DRUG: SC0191 + Bevacizumab
DRUG: SC0191 + 5-FU/LV

Sponsor

Tianshu Liu